Brief: Wuxi Biologics To Repurchase Shares Up To Us$400 Million In Open Market
26/05/2026 03:02
May 26 (Reuters) - WuXi Biologics (Cayman) Inc 2269.HK: TO REPURCHASE SHARES UP TO US$400 MILLION IN OPEN MARKET Further company coverage: 2269.HK ((Reuters.Briefs@thomsonreuters.com;))
Recent news on WuXi Biologics (Cayman)
See all newsWuXi Biologics hits 6-week high on confidence in delivering FY26 guidance
Brief: Wuxi Biologics Adds 69 Projects In Jan-April, Maintains Expected Revenue Growth
Viridian Therapeutics signs manufacturing deal with WuXi Biologics for thyroid eye disease drug
WuXi Biologics climbs most in six weeks on share repurchase plan
Brief: Wuxi Biologics To Repurchase Shares Up To Us$400 Million In Open Market